40 results
Page 2 of 2
424B5
7q5qygyi mb
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
7m3zy6o qs
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
EX-99.2
zbnaq6uy5jck9xw3xc
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.2
gl4w7jwdqbywfr0y3z
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
DEF 14A
xoypxe339v6zm 5r2
28 Apr 22
Definitive proxy
4:44pm
8-K
EX-99.1
ktp3pdem z5
13 Apr 22
Targeted Therapies for People of All Ages April 2022
8:01am
10-K
woo5d
7 Mar 22
Annual report
7:36am
8-K
EX-99.2
zxgr3dkner7k4fw2
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
8-K
EX-99.2
xm817v9w6vb3jg
5 Jan 22
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
8:01am
10-Q
m3f4zg s9rvwgp
10 Aug 21
Quarterly report
5:26pm
8-K
EX-99.2
kucvtp
10 Aug 21
Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
4:15pm
424B4
skq9folee4euyia
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
EX-4.1
5x3uiowklv6738 rfi
24 May 21
IPO registration (amended)
6:16am
S-1/A
9qqhhee16 5iktipm6oi
24 May 21
IPO registration (amended)
6:16am
S-1
deaaa5c
4 May 21
IPO registration
4:12pm
S-1
EX-10.4
2o7dzyz d16ur
4 May 21
IPO registration
4:12pm
DRS
52tbg1zzx z2ndd
19 Mar 21
Draft registration statement
12:00am